GastroEsophageal Cancer New Protocol: Perioperative Durvalumab with FLOT in Gastric Cancer Ulas D. Bayraktar, MD 2025-09-08
Non-Small Cell Lung Cancer New Reference: Neoadjuvant Nivolumab for NSCLC Ulas D. Bayraktar, MD 2025-09-08
Head and Neck Cancer New Indication: Periop Pembrolizumab for Head and Neck Cancer Ulas D. Bayraktar, MD 2025-09-08
Anal Cancer New Reference: Retifanlimab + Chemotherapy for Advanced Anal Cancer Ulas D. Bayraktar, MD 2025-09-08
Multiple Myeloma New Drug: Linvoseltamab for Relapsed/Refractory Myeloma Ulas D. Bayraktar, MD 2025-09-08
Nasopharyngeal Cancer New Drug: Penpulimab with Platinum – Gemcitabine in Advanced Nasopharyngeal Carcinoma Ulas D. Bayraktar, MD 2025-06-09
Non-Small Cell Lung Cancer New Drug: Telisotuzumab vedotin for cMET Amplified NSCLC Ulas D. Bayraktar, MD 2025-06-09
Breast Cancer New Reference: Inavolisib with Palbociclib and Fulvestrant for Advanced ER+ Breast Cancer Ulas D. Bayraktar, MD 2025-06-02
Prostate Cancer New Reference: Enzalutamide with Radium-223 for Prostate Cancer Ulas D. Bayraktar, MD 2025-06-02
Bladder Cancer New Reference: Enfortumab Vedotin + Pembrolizumab for Advanced Urothelial Carcinoma Ulas D. Bayraktar, MD 2025-06-02
